Dose-response study of SM-13496 in patients with schizophrenia [late Phase 2 study]
Latest Information Update: 14 Jun 2016
At a glance
- Drugs Lurasidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sumitomo Dainippon Pharma
- 14 Jun 2016 New trial record